Biomarkers in community-acquired pneumonia: A state-of-the-art review.

February 24, 2013 at 9:06 pm

Clinics (Sao Paulo). 2012 Nov;67(11):1321-5.

Seligman R, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Pacheco EF, Dalla Rosa K.

Source

Departamento de Medicina Interna, Hospital de ClÃ-nicas de Porto Alegre (HCPA), Faculdade de Medicina, Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

Abstract

Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488993/pdf/cln-67-11-1321.pdf

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Infecciones respiratorias, Metodos diagnosticos, REVIEWS, Sepsis.

Treatment of liver hydatidosis: how to treat an asymptomatic carrier? Update to CDC’s Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.


Calendar

February 2013
M T W T F S S
« Jan   Mar »
 123
45678910
11121314151617
18192021222324
25262728  

Most Recent Posts


%d bloggers like this: